Last Updated on June 2, 2017

GLEN ROCK, Pa. (April 7, 2009) – ARx, LLC, a subsidiary of Adhesives Research, is pleased to announce the creation of its billionth oral thin film strip (OTF). The billionth strip rolled through production on March 1, 2009.

The size of one OTF strip is smaller than a postage stamp, so one billion strips positioned end-to-end would span a distance of 2,485 miles, or 4000 kilometers. That’s longer than the Mississippi River and further than the distance from New York to Los Angeles.

“This is an incredible accomplishment for our team, particularly when you think that we have produced enough strips to lay end-to-end across the United States,” said Beth Vondrak VP/GM of ARx. “We are only just beginning our journey for OTFs. The dissolvable film technology is now being considered for a number of new applications in dermal, medical and biopharma applications.”

This milestone follows closely on the opening of ARx’s 25,000 sq. ft. pharmaceutical manufacturing facility. The stand-alone cGMP manufacturing facility is located on Adhesives Research’s Glen Rock, Pa., campus and operates multiple pharmaceutical manufacturing lines.

ARx develops and manufactures innovative drug delivery platforms, including custom-developed dissolvable film and adhesive platforms for oral drug delivery, transdermal drug delivery and biopharmaceuticals. The company is recognized as the first to develop and commercialize a systemically active combination OTF product and the first manufacturer to break the 50-mg load barrier for a dissolvable film strip. ARx’s dissolvable film technology, built on more than 20 years of proven coating technology, is now found in commercial dissolvable film products sold globally in the cough/cold, gastrointestinal and medical device categories.

ARx, LLC., a wholly-owned subsidiary of Adhesives Research, Inc., was created in 2005 to address the growing global need for innovative delivery of active drug-containing systems and is a custom developer and supplier of high-quality drug and biopharmaceutical delivery materials and technologies for the pharmaceutical industry. ARx’s state-of-the-art, pharmaceutical manufacturing facility is compliant with cGMP, FDA and global regulations for manufacturing pharmaceutical products. The facility triples ARx’s manufacturing capacity and laboratory space to support its rapidly growing portfolio of projects and clients. Adhesives Research has more than 20 years of experience in providing unique components for transdermal, oral and topical drug delivery.

For more information on ARx, LLC and Adhesives Research, Inc., please call 717-235-7979 (1-800-445-6240) or visit www.adhesivesresearch.com.